Gabapentin
| Material: | 1 ml serum |
| Methods: | Flüssigkeitschromatographie-Massenspektrometrie (LC-MS/MS) → LC-Tandem-Massenspektrometrie |
| Indication | Therapeutic drug monitoring |
| Therapeutic range | 2 mg/l – 20 mg/l |
| Please note | Gabapentin is an antiepileptic and structurally related to gamma-aminobutyric acid (GABA). Typical side effects of Gabapentin are sleepiness, vertigo, headache, vomiting, weight gain, paresthesia etc. Gabapentin is usually well tolerated, as even very high doses taken in suicidal intention, only lead to temporary side effects. |
| Accredited | ja |
More Results for the letter G
- Gabapentin (GABA)
- Galactose in the blood (GALA)
- Galactose in the urine (GALAU)
- Galactose-1-phosphate (GAL1)
- Galactose-1-phosphate uridyltransferase (GAL1PU)
- Gal-1-PUT
- Galactosemia-screening (GUTNEO)
- Galactosidase in leucocytes (α-) (GALA06(a))
- Gallstone analysis (GALST)
- Gamma-aminobutyric acid (GAMIN)
- Gamma-GT (GGT)
- GGT, gamma-glutamyl-transpeptidase or -transferase
- Gamma-hydroxy-butyric acid (GHYDRO)
- GHB, liquid ecstasy, knockout drops
- Ganglioside autoantibodies (GANG)
- GQ1b-, GM1-, GM2., GM3-, GD1a-, GD1b-, GT1b-antibodies
- Gardnerella vaginalis (KGARD, GARVAG)
- Gas gangrene (GASBR)
- Clostridium perfringens, novyi, septicum, histolyticum
- Gastrin (GAS)
- Gastrin-producing cells, autoantibodies against (GBZ)
- Gentamicin (GENTA)
- Germanium (GER)
- GLDH (GLDH)
- Glutamate-dehydrogenase
- Gliadin-antibodies (deamidated) IgA and IgG (GLIAS)
- Glomerular basal membrane autoantibodies (GBM)
- GBM antibodies
- Glucagon (GLUK)
- Glucose (GL)
- Plasma glucose
- Glucose metabolism diagnostics (in blood, fasting) (GLUN)
- Glucose metabolism diagnostics (in CSF) (GLUL)
- Glucose-6-phosphate dehydrogenase (GLU6P)
- G6PDH
- Glutamate-decarboxylase autoantibodies (GAD)
- GAD-antibodies
- Glutaric acid (GLUTAR)
- Glutathione (GLUTAT)
- Goblet cells autoantibodies (GOBL)